Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
Srikanth MuppidiKimiaki UtsugisawaMichael BenatarHiroyuki MuraiRichard J BarohnIsabel IllaSaiju JacobJohn VissingTed M BurnsJohn T KisselRichard J NowakHenning AndersenCarlos CasasnovasJan L de BleeckerTuan H VuRenato MantegazzaFanny L O'BrienJing Jing WangKenji P FujitaJames F Howardnull nullPublished in: Muscle & nerve (2019)
These findings provide evidence for the long-term safety and sustained efficacy of eculizumab for refractory gMG. Muscle Nerve 2019.